Paramesu Biotech IPO

Paramesu Biotech IPO GMP, Details, Guidance, Subscription Status, allotment @ Chanakyanipothi.com
A legacy of 31 Years.
India`s Oldest Investment & IPO website.
Most Trusted by Investors across India.

Table of Contents

What is the latest news relating to Paramesu Biotech IPO?   

On 28th February 2025, the company has received green signal to its IPO.

What is the latest GMP of Paramesu Biotech IPO?   
Click

Paramesu Biotech IPO Subscriptions
(IPO yet to open)

Price Rs. – Lot – shares, Net Rs. – Crore

QIB B HNI X S HNI X NII X RII X Total X
           
Applications:  / (?x)
Amount wise Bids recd. Rs. ? Crore

 

What are the promoters of Paramesu Biotech IPO?   
THE PROMOTERS OF OUR COMPANY ARE: UNIMARK BUSINESS SOLUTIONS PRIVATE LIMITED, SPEEDFAST TRACOM LIMITED, ANANDA SWAROOP ADAVANI, MANI SWETHA TETALI AND HIMABINDU TETALI

 

What are the Objects of Paramesu Biotech IPO?

The Company intends to utilise the Net Proceeds from the Issue towards funding the following objects:

  1. Funding the capital expenditure requirement for setting up of new plant of 1200 TPD at the Proposed Facility in Mohasa – Babai, District Narmadapuram, Madhya Pradesh.
  2. 2. Repayment and/ or pre-payment, in part or full, of certain borrowings availed by the Company; and
  3. 3. General Corporate Purposes.

What is the business of Paramesu Biotech?

Paramesu Biotech is one of India’s largest manufacturers of maize-based specialty products, with an installed capacity of 800 TPD (tons per day) (Source: F&S Report). The company offers a diverse range of maize-based products, including native maize starch, modified maize starches, liquid glucose, maltodextrin powder, and co-products like germs, gluten, fiber, corn steep liquor, and enriched fiber.

With a capacity utilization rate of 93.09% in FY 2024, Paramesu Biotech stands out among its peers (Source: F&S Report). It is one of the few companies in India specializing in various types of modified starches, including dextrin, pre-gelatinized starch, thin boiled starch, cationic starch, oxidized starch, and spray starch (Source: F&S Report).

The company operates its production unit in Devarapalli, West Godavari District, Andhra Pradesh, and has established a strong presence both domestically and internationally. Paramesu Biotech’s products are sold across 14 states and 4 union territories in India, and the company exports to over 10 countries in South East Asia and the Middle East. It is also a recognized Two Star Export House by the Indian Ministry of Commerce.

The company’s Devarapalli facility, covering 2.63 million square feet (approximately 60.29 acres), is strategically located near major maize harvesting regions, export ports, and key transport routes, optimizing its business operations.

For more information, click www.paramesu.com 

Paramesu Biotech IPO GMP, Particulars & Guidance

 IPO Details 
IPO opens on  Yet to announce
IPO closes on  Yet to announced
Issue Type Book Built Issue IPO
Issue Size ? Sh /
Rs 600 Crore
* Fresh Issue ? Sh /
Rs 520 Crore
* Offer for Sale  – Shares /
Rs 80 Crore
   
Face Value per share: Rs. 5
Price Band  Yet to announce
Retail Discount  Rs 0 per share
Employee discount  Rs. 0 per share
Retail Lot Size  Yet to announce
Listing will at  BSE, NSE
Shares offered in
this IPO?
Shares Rs.
in Crore
QIB (50 %)     
NII (15 %)     
RII (35 %)     
Employees    
Total Shares     
Retail portion will be oversubscribed by   Forms.
How to apply in this IPO? Amount
Rs.
Min Retail Application    
Max Retail Application     
Small HNI (Min) application     
Small HNI (Max) application    
Big HNI Application    
What is the timetable of the IPO?
IPO opens on Yet to announce
IPO Closes on Yet to announce
IPO Allotment on Yet to announce
Unblocking of Asba Yet to announce
Credit of Shares Yet to announce
Listing of Shares Yet to announce
Registered Office of the company
RS No. 972, 3rd KM on Gopalapuram Road,
West Godavari,
Devarapalli – 534 313,
Andhra Pradesh, India

Lead Managers of the IPO
Pantomath Capital Advisors
Registrar to IPO
Bigshare Services Pvt ltd
Paramesu Biotech IPO Financial & Analytical Ratios
Year Total Income Net Profit EPS RoNW
  Rs. in Cr Rs.in Cr Rs. %
2021-22 496.60 33.97 1.29 23.30
2022-23 625.34 32.52 1.24 24.46
2023-24 629.29 40.34 1.54 33.65
Book Value of the Share
on 31.3.2024
  6.29    
BV of the Share after
the IPO
Rs.    
Offer Price at Cap Rs.  ?    
IPO Ratio Analysis
Price /EPS ?
Price/Book Value  ?
Price/BV after IPO  ?

How Paramesu Biotech IPO compares with the Peers?
Peer Comparison.

As on date of DRHP FV Total  PE
  Rs. Income Ratio of
    Rs. In Cr  
Paramesu Bitech 5 629.29  
Sanstar ltd 2 1081.68 24.82
Gujarat Ambuja Expo. 1 5071.42 16.38
Gulshan Polyols 1 1390.18 71.67
Sukhjit Starch 5 1385.03 15.67
       
       
       

# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.

Paramesu Biotech IPO Guidance by Paresh Gordhandas, CA & Research Analyst.

We shall post our review once the price, lot and other updates are available to us.

Quicklinks

Paramesu Biotech IPO GMP

Paramesu Biotech IPO GMP today details

Paramesu Biotech IPO GMP today, Details, Guidance, Subscription Status, allotment

Leave a Reply

Your email address will not be published. Required fields are marked *